Center-Authored Papers

Filters: Author is Collier, Ann C  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Collier AC, Chun T-W, Maenza J, Coombs RW, Tapia K, Chang M, Stevens CE, Justement SJ, Murray D, Stekler JD et al..  2016.  A Pilot Study of Raltegravir Plus Combination Antiretroviral Therapy in Early Human Immunodeficiency Virus Infection: Challenges and Lessons Learned.. BioResearch open access. 5(1):15-21. Abstract
D
Dinges WL, Richardt J, Friedrich D, Jalbert E, Liu Y, Stevens CE, Maenza J, Collier AC, Geraghty DE, Smith J et al..  2010.  Virus-specific CD8+ T-cell responses better define HIV disease progression than HLA genotype.. Journal of virology. 84(9):4461-8. Abstract
E
Elahi S, Dinges WL, Lejarcegui N, Laing KJ, Collier AC, Koelle DM, McElrath MJ, Horton H.  2011.  Protective HIV-specific CD8(+) T cells evade T(reg) cell suppression.. Nature medicine. 17(8):989-95. Abstract
H
Hecht FM, Wellman R, Busch MP, Pilcher CD, Norris PJ, Margolick JB, Collier AC, Little SJ, Markowitz M, Routy J-P et al..  2011.  Identifying the Early Post-HIV Antibody Seroconversion Period.. The Journal of infectious diseases. 204(4):526-533. Abstract
Herbeck JT, Rolland M, Liu Y, McLaughlin S, McNevin J, Zhao H, Wong K, Stoddard JN, Raugi D, Sorensen S et al..  2011.  Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes.. Journal of virology. 85(15):7523-34. Abstract
K
Kraft JC, McConnachie LA, Koehn J, Kinman L, Collins C, Shen DD, Collier AC, Ho RJY.  2017.  Long-acting combination anti-HIV drug suspension enhances and sustains higher drug levels in lymph node cells than in blood cells and plasma.. AIDS (London, England). Abstract
Krishnan S, Schouten JT, Jacobson DL, Benson CA, Collier AC, Koletar SL, Santana J, Sattler FR, Mitsuyasu R.  2011.  Incidence of non-AIDS-defining cancer in antiretroviral treatment-naïve subjects after antiretroviral treatment initiation: an ACTG longitudinal linked randomized trials analysis.. Oncology. 80(1-2):42-9. Abstract
Kunwar P, Hawkins N, Dinges WL, Liu Y, Gabriel EE, Swan DA, Stevens CE, Maenza J, Collier AC, Mullins JI et al..  2013.  Superior Control of HIV-1 Replication by CD8+ T Cells Targeting Conserved Epitopes: Implications for HIV Vaccine Design.. PloS one. 8(5):e64405. Abstract
L
Liu Y, McNevin J, Rolland M, Zhao H, Deng W, Maenza J, Stevens CE, Collier AC, McElrath MJ, Mullins JI.  2009.  Conserved HIV-1 epitopes continuously elicit subdominant cytotoxic T-lymphocyte responses.. The Journal of infectious diseases. 200(12):1825-33. Abstract
M
Maenza J, Tapia K, Holte S, Stekler JD, Stevens CE, Mullins JI, Collier AC.  2015.  How often does treatment of primary HIV lead to post-treatment control? Antiviral therapy. Abstract
S
Smurzynski M, Wu K, Schouten JT, Lok JJ, Bosch RJ, Taiwo B, Johnson VA, Collier AC.  2013.  Factors associated with remaining on initial randomized efavirenz-containing regimens.. AIDS (London, England). 27(12):1887-97. Abstract
Stekler JD, Ellis GM, Carlsson J, Eilers B, Holte S, Maenza J, Stevens CE, Collier AC, Frenkel LM.  2011.  Prevalence and Impact of Minority Variant Drug Resistance Mutations in Primary HIV-1 Infection.. PloS one. 6(12):e28952. Abstract
Stekler JD, McKernan J, Milne R, Tapia KA, Mykhalchenko K, Holte S, Maenza J, Stevens CE, Buskin SE, Mullins JI et al..  2014.  Lack of resistance to integrase inhibitors among antiretroviral-naive subjects with primary HIV-1 infection, 2007-2013.. Antiviral therapy. Abstract
Stekler J, Sycks BJ, Holte S, Maenza J, Stevens CE, Dragavon J, Collier AC, Coombs RW.  2008.  HIV dynamics in seminal plasma during primary HIV infection.. AIDS research and human retroviruses. 24(10):1269-74. Abstract
Sunshine JE, Larsen BB, Maust B, Casey E, Deng W, Chen L, Westfall DH, Kim M, Zhao H, Ghorai S et al..  2015.  Fitness-balanced escape determines resolution of dynamic founder virus escape processes in HIV-1 infection.. Journal of virology. Abstract